Euro-BioImaging update regarding COVID-19
Following closely the Covid-19 situation, Euro-BioImaging asks everyone involved, including Euro-BioImaging users, to align with the recommendations of their relevant national health departments.
Euro-BioImaging will process the online submission of new user proposals as before, but flexibility needs to be applied when it comes to scheduling a physical user visit until available information on the European situation allows again for reliable and safe travel planning. Euro-BioImaging is also looking into the implementation of additional activities and services that do not require physical traveling and ways to keep a constructive momentum during these exceptional times.
Regarding any upcoming meetings, Euro-BioImaging will continue following the general development and act in accordance.
More news from Euro-BioImaging
October 21, 2024
ILLUMINATE brings together private-public partners to advance novel theranostics-based cancer treatments
Euro-BioImaging is thrilled to be part of ILLUMINATE (Increasing Lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership…